Cetuximab (Erbitux) in Combination With Cisplatin or Carboplatin and 5-Fluorouracil in the First Line Treatment of Subjects With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck (EXTREME)
PHASE3
The purpose of this trial is to investigate the efficacy of cetuximab in co...
A Single-center Phase II Study to Investigate the Immune Maintenance Therapy Pattern in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma Who Have Achieved MPR After Neoadjuvant Immunotherapy Combined With Chemotherapy
PHASE2
Head and neck cancer is the malignant tumor with the highest morbidity and ...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital